Start Living Today!

Start Living Today!

Have you waited until retirement to start living a happy life?  Find out how to start living now.  Enjoy our site and please feel free to ask questions about health information and medications, post to our blogs, or make comments.

Login/Register



 Apr   May 2012   Jun

SMTWTFS
   1  2  3  4  5
  6  7  8  9101112
13141516171819
20212223242526
2728293031 
Julianna Walker Willis Technology
Sponsored Links

Advertisement

sovereign

 

Expert SEO

 

 

1st  24th  2nd  [in  [the  ability  able  abpa  absolutely  abuse  accept  access  according  achieved  achieving  act  active  activities  activity  actually  additional  adds  administer  administration  adults  advancing  advantage  adversity  affairs  affected  afford  affordable  africa  age  agent  ages  aggravated  aggressively  aging  agriculture 

Novavax Reports Positive Results From Pre-Clinical Safety Study Of Respiratory Syncytial Virus (RSV) Vaccine Candidate

PostDateIconWednesday, 18 August 2010 12:38 | PDF | Print | E-mail
Novavax, Inc. (Nasdaq: NVAX) reported that results from a pre-clinical toxicology study of its vaccine candidate to prevent respiratory syncytial virus (RSV), showed the vaccine to be safe and well-tolerated at all doses tested. Novavax's vaccine uses highly purified recombinant particles of RSV-F fusion (RSV-F) protein normally found in the virus...
read full article
 
Copyright Retire Today  2010 ©  
All rights reserved